The Asia-Pacific region has once again shown its strength in the 2015 Scientific American Worldview Scorecard rankings, holding three of the Top Five spots.

Released at this year’s BIO International Convention, the report evaluates countries on key factors that power biotechnology success. Life science innovation potential is measured using seven categories: productivity, IP protection, intensity, education/workforce, enterprise support, foundations, and policy and stability.

Much like last year (see our article here), New Zealand showed strength in scientific capabilities and political stability, Australia was noted for its public companies, and Singapore for its patent environment. Based on these advantages, New Zealand moved into third (bumping Sweden out of the top group), Australia maintained its fourth place ranking, and Singapore ranked fifth. Rounding out the Top Five were Denmark and regular top seed, the United States.

Dr Will Barker, CEO of NZBIO remarked on New Zealand’s surge in the rankings: “It is fantastic to be recognised in such a prestigious international study.” He sees space for growth too, noting, “There is room in NZ for significant improvement in both public and private R&D spending and investment, which is very low compared with the other top 10 countries.”

As well as ranking countries, the report highlights 100 people who are reshaping biotechnology. Among them was Dr Anna Lavelle, the CEO of AusBiotech, who commented that “It’s a great honour to be recognised in this way, but especially to be named as the only Australian and amongst a global group of respected, visionary and eminent people.”

Read the full report here.

By Emma Armitage, Business Analyst, BioPacific Partners


About Emma Armitage

No Comments

Be the first to start a conversation

Leave a Reply

  • (will not be published)